Parallax Health Sciences Inc (OTCMKTS:PRLX) has launched its Good Health Outcomes app, a free diagnostic and remote patient monitoring program available on Apple’s App Store and the Google Play Store.
The app provides secure, HIPAA-compliant communication with any healthcare provider and can transmit biometric data. That way, if a patient has a fever or a dry cough, a doctor can prioritize hospital admissions or even send a clinician to provide coronavirus (COVID-19) testing.
Nathaniel Bradley, Parallax’s Chief Technology Officer and the architect of the app, believes it can take some of the strain caused by the coronavirus off of hospitals.
READ: Parallax moves one step closer to a finished coronavirus test by securing antigens and anitbodies to use as markers
"Our healthcare system is being stressed to its limits, on all fronts by the coronavirus, and America's hospitals are facing one of their greatest threats to their continued operations." Bradley said in a statement.
"The hospital system will reach a tipping point, sooner rather than later, and we all must look at ways to reduce mass admissions if we can do so. America's hospital system cannot take the projected onslaught of people all coming into the ER in a compressed time period, without some way to prioritize admission."
Parallax is headquartered in New York City, which has seen nearly 15,000 confirmed cases and 192 deaths from the coronavirus, according to ABC News.
"Being based here in New York City and seeing firsthand how this virus and its impact are affecting lives, I cannot stress enough the urgency of a great Telehealth solution such as the Good Health Outcomes platform,” Parallax CEO Paul Arena said.
"We hope people take advantage of this at a time where we all need to just stay put in our homes if we can do so. People can go and download for free and then go to the Good Health Outcomes site to sign in and follow directions."
Parallax is an outcomes-driven telehealth company that focuses on cost-effective remote diagnosis, treatment and monitoring of patients with chronic diseases.
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel